Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Vita Therapeutics
company
About
Vita Therapeutics is a cell engineering company that develops life-transformative treatments.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $31M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Vita Therapeutics is a cell engineering company that develops life-transformative treatments. Vita utilizes induced pluripotent stem cell technology to engineer specific cell types designed to replace those that are defective in patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$63M
Vita Therapeutics has raised a total of
$63M
in funding over 2 rounds. Their latest funding was raised on
Oct 12, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 12, 2022 | Series B | $31M | 2 | — | — | Detail |
| Jun 23, 2021 | Series A | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Vita Therapeutics is funded by 3 investors.
TEDCO
and Riptide Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
TEDCO
|
— | Series B |
Riptide Ventures
|
— | Series B |
SCM Life Sciences
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
